{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:36:44Z","timestamp":1785476204821,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-03031-0","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:48:37Z","timestamp":1732776517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A novel pan-epitope based nanovaccine self-assembled with CpG enhances immune responses against flavivirus"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiuxiang","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"3031_CR1","doi-asserted-by":"publisher","first-page":"S935","DOI":"10.1093\/infdis\/jix515","volume":"216","author":"D Sirohi","year":"2017","unstructured":"Sirohi D, Kuhn RJ. Zika Virus structure, maturation, and receptors. J Infect Dis. 2017;216:S935\u201344.","journal-title":"J Infect Dis"},{"key":"3031_CR2","doi-asserted-by":"crossref","unstructured":"Yen L-C, Chen H-W, Ho C-L, Lin C-C, Lin Y-L, Yang Q-W, et al. Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement. J Biomed Sci. 2023;30:41.","DOI":"10.1186\/s12929-023-00938-y"},{"key":"3031_CR3","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","volume":"184","author":"A Sharma","year":"2021","unstructured":"Sharma A, Zhang X, Dejnirattisai W, Dai X, Gong D, Wongwiwat W, Duquerroy S, Rouvinski A, Vaney MC, Guardado-Calvo P, et al. The epitope arrangement on flavivirus particles contributes to Mab C10\u2019s extraordinary neutralization breadth across Zika and dengue viruses. Cell. 2021;184:6052\u2013e60666018.","journal-title":"Cell"},{"key":"3031_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.clinthera.2017.07.001","volume":"39","author":"MH Collins","year":"2017","unstructured":"Collins MH, Metz SW. Progress and Works in Progress: update on Flavivirus Vaccine Development. Clin Ther. 2017;39:1519\u201336.","journal-title":"Clin Ther"},{"key":"3031_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","volume":"36","author":"AE Ngono","year":"2018","unstructured":"Ngono AE, Shresta S. Immune Response to Dengue and Zika. Annu Rev Immunol. 2018;36:279\u2013308.","journal-title":"Annu Rev Immunol"},{"key":"3031_CR6","first-page":"204993612311672","volume":"10","author":"R Kariyawasam","year":"2023","unstructured":"Kariyawasam R, Lachman M, Mansuri S, Chakrabarti S, Boggild AK. A dengue vaccine whirlwind update. Ther Adv Infect Dis. 2023;10:20499361231167274.","journal-title":"Ther Adv Infect Dis"},{"key":"3031_CR7","doi-asserted-by":"crossref","unstructured":"Li X-F, Cui Z, Fan H, Chen Q, Cao L, Qiu H-Y, et al. A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters. Innovation (Camb). 2022;3(2):100221.","DOI":"10.1016\/j.xinn.2022.100221"},{"key":"3031_CR8","doi-asserted-by":"crossref","unstructured":"Tlaxca JL, Ellis S, Remmele RLJADDR. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges. Adv Drug Deliv Rev. 2015;93:56\u201378.","DOI":"10.1016\/j.addr.2014.10.002"},{"key":"3031_CR9","doi-asserted-by":"publisher","first-page":"1161149","DOI":"10.3389\/fimmu.2023.1161149","volume":"14","author":"Z Huang","year":"2023","unstructured":"Huang Z, Zhang Y, Li H, Zhu J, Song W, Chen K, Zhang Y, Lou Y. Vaccine development for mosquito-borne viral diseases. Front Immunol. 2023;14:1161149.","journal-title":"Front Immunol"},{"key":"3031_CR10","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/acs.accounts.0c00438","volume":"53","author":"E Froimchuk","year":"2020","unstructured":"Froimchuk E, Carey ST, Edwards C, Jewell CM. Self-assembly as a Molecular Strategy to Improve Immunotherapy. Acc Chem Res. 2020;53:2534\u201345.","journal-title":"Acc Chem Res"},{"key":"3031_CR11","doi-asserted-by":"crossref","unstructured":"Wang N, Shang J, Jiang S, Du L. Subunit vaccines against emerging pathogenic human coronaviruses. Front Microbiol. 2020;11:298.","DOI":"10.3389\/fmicb.2020.00298"},{"key":"3031_CR12","doi-asserted-by":"publisher","first-page":"e2100985","DOI":"10.1002\/advs.202100985","volume":"8","author":"AO Shalash","year":"2021","unstructured":"Shalash AO, Hussein WM, Skwarczynski M, Toth I. Key considerations for the development of safe and effective SARS-CoV-2 Subunit Vaccine: a peptide-based Vaccine Alternative. Adv Sci (Weinh). 2021;8:e2100985.","journal-title":"Adv Sci (Weinh)"},{"key":"3031_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2018.10.008","volume":"292","author":"R Zhang","year":"2018","unstructured":"Zhang R, Billingsley MM, Mitchell MJ. Biomaterials for vaccine-based cancer immunotherapy. J Control Release. 2018;292:256\u201376.","journal-title":"J Control Release"},{"key":"3031_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2020.12.011","volume":"29","author":"DR Martinez","year":"2021","unstructured":"Martinez DR, Metz SW, Baric RS. Dengue vaccines: the Promise and pitfalls of antibody-mediated Protection. Cell Host Microbe. 2021;29:13\u201322.","journal-title":"Cell Host Microbe"},{"key":"3031_CR15","doi-asserted-by":"crossref","unstructured":"Song J, Wang M, Zhou L, Tian P, Sun Z, Sun J, et al. A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response. J Nanobiotechnol. 2023;21:424.","DOI":"10.1186\/s12951-023-02210-9"},{"key":"3031_CR16","doi-asserted-by":"crossref","unstructured":"Liu Z-H, Deng Z-F, Lu Y, Fang W-H, He F. A modular and self-adjuvanted multivalent vaccine platform based on porcine Circovirus virus-like nanoparticles. J Nanobiotechnol. 2022;20:493.","DOI":"10.1186\/s12951-022-01710-4"},{"key":"3031_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/erv.10.174","volume":"10","author":"C Bode","year":"2014","unstructured":"Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2014;10:499\u2013511.","journal-title":"Expert Rev Vaccines"},{"key":"3031_CR18","doi-asserted-by":"crossref","unstructured":"Cooper CL, Davis HL, Morris ML, Efler SM, Krieg AM, Li Y, et al. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine. 2004;22:3136\u201343.","DOI":"10.1016\/j.vaccine.2004.01.058"},{"key":"3031_CR19","doi-asserted-by":"crossref","unstructured":"Nanishi E, Borriello F, O\u2019Meara TR, Mcgrath ME, Dowling DJJSTM. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Sci Transl Med. 2021;14(629):eabj5305.","DOI":"10.1126\/scitranslmed.abj5305"},{"key":"3031_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biomaterials.2016.11.020","volume":"115","author":"J-O Jin","year":"2017","unstructured":"Jin J-O, Park H, Zhang W, de Vries JW, Gruszka A, Lee MW, Ahn D-R, Herrmann A, Kwak M. Modular delivery of CpG-incorporated lipid-DNA nanoparticles for spleen DC activation. Biomaterials. 2017;115:81\u20139.","journal-title":"Biomaterials"},{"key":"3031_CR21","doi-asserted-by":"crossref","unstructured":"Kim H, Zhang W, Hwang J, An E-K, Choi YK, Moon E, et al. Carrier-free micellar CpG interacting with cell membrane for enhanced immunological treatment of HIV-1. Biomaterials. 2021;277:121081.","DOI":"10.1016\/j.biomaterials.2021.121081"},{"key":"3031_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1039\/D0BM01333A","volume":"9","author":"D Liu","year":"2021","unstructured":"Liu D, Liu J, Ma B, Deng B, Leng X, Kong D, Liu L. A simple self-adjuvanting biomimetic nanovaccine self-assembled with the conjugate of phospholipids and nucleotides can induce a strong cancer immunotherapeutic effect. Biomaterials Sci. 2021;9:84\u201392.","journal-title":"Biomaterials Sci"},{"key":"3031_CR23","doi-asserted-by":"crossref","unstructured":"Du JJ, Wang CW, Xu WB, Zhang L, Tang YK, Zhou SH, Gao XF, Yang GF, Guo J. Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses. iScience 2020, 23:100935.","DOI":"10.1016\/j.isci.2020.100935"},{"key":"3031_CR24","doi-asserted-by":"crossref","unstructured":"Mellman IJC. Dendritic cells: specialized and regulated antigen processing machines. 2001, 106.","DOI":"10.1016\/S0092-8674(01)00449-4"},{"key":"3031_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fimmu.2019.00059","volume":"10","author":"AB Zaneti","year":"2019","unstructured":"Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida BDS, Souza HFS, Ferreira NS, Maeda D, Sales NS, Rosa DS, Ferreira LCS, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4(+) T cells to the Dengue Virus envelope protein domain III. Front Immunol. 2019;10:59.","journal-title":"Front Immunol"},{"key":"3031_CR26","doi-asserted-by":"crossref","unstructured":"Valerio-Bolas A, Meunier M, Palma-Marques J, Rodrigues A, Santos AM, Nunes T, et al. Exploiting Leishmania-primed dendritic cells as potential immunomodulators of Canine Immune Response. Cells. 2024;13:445.","DOI":"10.3390\/cells13050445"},{"key":"3031_CR27","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","volume":"120","author":"RJ Malonis","year":"2019","unstructured":"Malonis RJ, Lai JR, Vergnolle O. Peptide-based vaccines: current Progress and Future challenges. Chem Rev. 2019;120:3210\u201329.","journal-title":"Chem Rev"},{"key":"3031_CR28","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1007\/s12274-023-5395-6","volume":"16","author":"J Nie","year":"2023","unstructured":"Nie J, Wang Q, Jin S, Yao X, Xu L, Chang Y, Ding F, Li Z, Sun L, Shi Y, Shan Y. Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus. Nano Res. 2023;16:7337\u201346.","journal-title":"Nano Res"},{"key":"3031_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.biotechadv.2017.05.002","volume":"35","author":"M Negahdaripour","year":"2017","unstructured":"Negahdaripour M, Golkar N, Hajighahramani N, Kianpour S, Nezafat N, Ghasemi Y. Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biotechnol Adv. 2017;35:575\u201396.","journal-title":"Biotechnol Adv"},{"key":"3031_CR30","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1016\/j.apsb.2022.03.017","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Jiang M, Du G, Zhong X, He C, Qin M, Hou Y, Liu R, Sun X. An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer. Acta Pharm Sinica B. 2023;13:3518\u201334.","journal-title":"Acta Pharm Sinica B"},{"key":"3031_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.actbio.2022.01.004","volume":"141","author":"H Song","year":"2022","unstructured":"Song H, Su Q, Shi W, Huang P, Zhang C, Zhang C, Liu Q, Wang W. Antigen epitope-TLR7\/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy. Acta Biomater. 2022;141:398\u2013407.","journal-title":"Acta Biomater"},{"key":"3031_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2019.09.013","volume":"315","author":"J-O Jin","year":"2019","unstructured":"Jin J-O, Kim H, Huh YH, Herrmann A, Kwak M. Soft matter DNA nanoparticles hybridized with CpG motifs and peptide nucleic acids enable immunological treatment of cancer. J Controlled Release. 2019;315:76\u201384.","journal-title":"J Controlled Release"},{"key":"3031_CR33","doi-asserted-by":"crossref","unstructured":"He C, Yang J, Hong W, Chen Z, Peng D, Lei H, et al. A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant. Nat Commun. 2022;13:5459.","DOI":"10.1038\/s41467-022-33209-9"},{"key":"3031_CR34","doi-asserted-by":"publisher","first-page":"689187","DOI":"10.3389\/fimmu.2021.689187","volume":"12","author":"ZH Liu","year":"2021","unstructured":"Liu ZH, Xu HL, Han GW, Tao LN, Lu Y, Zheng SY, Fang WH, He F. Self-assembling Nanovaccine enhances protective efficacy against CSFV in pigs. Front Immunol. 2021;12:689187.","journal-title":"Front Immunol"},{"key":"3031_CR35","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3389\/fmicb.2020.01961","volume":"11","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang Y, Zou P, Wang M, Fu W, She J, Song Z, Xu J, Huang J, Wu F. Self-assembly M2e-Based peptide nanovaccine confers Broad Protection against Influenza viruses. Front Microbiol. 2020;11:1961.","journal-title":"Front Microbiol"},{"key":"3031_CR36","doi-asserted-by":"crossref","unstructured":"Chan Y, Jazayeri SD, Ramanathan B, Poh CL. Enhancement of Tetravalent Immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles. Vaccines (Basel). 2020;8:417.","DOI":"10.3390\/vaccines8030417"},{"key":"3031_CR37","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1080\/21505594.2021.1996059","volume":"12","author":"SW van Leur","year":"2021","unstructured":"van Leur SW, Heunis T, Munnur D, Sanyal S. Pathogenesis and virulence of flavivirus infections. Virulence. 2021;12:2814\u201338.","journal-title":"Virulence"},{"key":"3031_CR38","doi-asserted-by":"crossref","unstructured":"Messer, William B, Gubler, Duane J. Harris, Eva, Sivananthan, diseases KJEI: emergence and global spread of a Dengue serotype 3. Subtype III Virus; 2003.","DOI":"10.3201\/eid0907.030038"},{"key":"3031_CR39","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s00705-018-3856-0","volume":"163","author":"FB Sulczewski","year":"2018","unstructured":"Sulczewski FB, Liszbinski RB, Rom\u00e3o PRT, Rodrigues Junior LC. Nanoparticle vaccines against viral infections. Arch Virol. 2018;163:2313\u201325.","journal-title":"Arch Virol"},{"key":"3031_CR40","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1039\/C4OB00447G","volume":"12","author":"D Mandal","year":"2014","unstructured":"Mandal D, Nasrolahi Shirazi A, Parang K. Self-assembly of peptides to nanostructures. Org Biomol Chem. 2014;12:3544\u201361.","journal-title":"Org Biomol Chem"},{"key":"3031_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.apsb.2018.12.001","volume":"9","author":"X Jiao","year":"2019","unstructured":"Jiao X, Yu Y, Meng J, He M, Zhang CJ, Geng W, Ding B, Wang Z, Ding X. Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy. Acta Pharm Sinica B. 2019;9:381\u201396.","journal-title":"Acta Pharm Sinica B"},{"key":"3031_CR42","doi-asserted-by":"crossref","unstructured":"Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M. Pathogen recognition and development of particulate vaccines: does size matter? Methods. 2006;40:1\u20139.","DOI":"10.1016\/j.ymeth.2006.05.016"},{"key":"3031_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.biomaterials.2017.01.010","volume":"122","author":"Q Zeng","year":"2017","unstructured":"Zeng Q, Li H, Jiang H, Yu J, Wang Y, Ke H, Gong T, Zhang Z, Sun X. Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines. Biomaterials. 2017;122:105\u201313.","journal-title":"Biomaterials"},{"key":"3031_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1381612823666170913163904","volume":"24","author":"K Reginald","year":"2018","unstructured":"Reginald K, Chan Y, Plebanski M, Poh CL. Development of peptide vaccines in Dengue. Curr Pharm Des. 2018;24:1157\u201373.","journal-title":"Curr Pharm Des"},{"key":"3031_CR45","doi-asserted-by":"crossref","unstructured":"Yang Z, Hua L, Yang M, Li W, Ren Z, Zheng X, et al. Polymerized porin as a novel delivery platform for coronavirus vaccine. J Nanobiotechnol. 2022;20:260.","DOI":"10.1186\/s12951-022-01469-8"},{"key":"3031_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jconrel.2021.02.029","volume":"332","author":"Z Lu","year":"2021","unstructured":"Lu Z, Zhang Y, Wang Y, Tan G-H, Huang F-Y, Cao R, He N, Zhang L. A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy. J Controlled Release. 2021;332:245\u201359.","journal-title":"J Controlled Release"},{"key":"3031_CR47","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2174\/1389203719666180531122724","volume":"19","author":"YW Huang","year":"2018","unstructured":"Huang YW, Lee CT, Wang TC, Kao YC, Yang CH, Lin YM, Huang KS. The development of peptide-based Antimicrobial agents against Dengue Virus. Curr Protein Pept Sci. 2018;19:998\u20131010.","journal-title":"Curr Protein Pept Sci"},{"key":"3031_CR48","doi-asserted-by":"publisher","first-page":"e0262321","DOI":"10.1371\/journal.pone.0262321","volume":"18","author":"DW Biner","year":"2023","unstructured":"Biner DW, Grosch JS, Ortoleva PJ. B-cell epitope discovery: the first protein flexibility-based algorithm-Zika virus conserved epitope demonstration. PLoS ONE. 2023;18:e0262321.","journal-title":"PLoS ONE"},{"key":"3031_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcv.2018.09.020","volume":"108","author":"JH Aberle","year":"2018","unstructured":"Aberle JH, Koblischke M, Stiasny K. CD4 T cell responses to flaviviruses. J Clin Virol. 2018;108:126\u201331.","journal-title":"J Clin Virol"},{"key":"3031_CR50","unstructured":"Muthusamy K, Gopinath K, Nandhini DJTIJMR. Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination. Indian J Med Res. 2016;144:587\u201391."},{"key":"3031_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jalz.2013.12.003","volume":"10","author":"H Davtyan","year":"2014","unstructured":"Davtyan H, Ghochikyan A, Petrushina I, Hovakimyan A, Davtyan A, Cribbs DH, Agadjanyan MG. The MultiTEP platform-based Alzheimer\u2019s disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates. Alzheimers Dement. 2014;10:271\u201383.","journal-title":"Alzheimers Dement"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03031-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-03031-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03031-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:11:23Z","timestamp":1732785083000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-03031-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-03031-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures in this study were approved by the Laboratory Animal Welfare and Ethics Committee of the Third Military Medical University (AMUWEC20240036).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"738"}}